Zubiete-Franco, I., Hu, Q., Alves, S. R., Utama, R., Tonks, N. K. (2026). Ganaxolone, an approved therapy for CDKL5-deficiency disorder, is an inhibitor of PTP1B. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.113178